Patent Application
20250034074
The present invention relates to the field of organic synthesis and more specifically it concerns a process for preparing compound of formula (I) comprising the reaction of a compound of the formula (II) with a base having a boiling point superior to the boiling point of the compound of formula (I). Moreover, the compound of formula (I) and the compound of formula (II) are also part of the invention.
The conjugated cyclic derivatives represent skeletons highly desirables which could be used as such or as key intermediates useful to prepare more complex compounds in different fields such as, among others, perfumery, cosmetic, pharmaceutic or agrochemistry. Relevant conjugated cyclic derivatives in perfumery industry are, for example, 1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-en-1-one or ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, particularly appreciated for their floral odor. Those perfuming ingredients represent some of the most sought-after ingredients in the perfumery industry. The methods known in the art to prepare those compounds, such as elimination step, provide a mixture of several regioisomers, also known as alpha, beta and gamma isomers, impossible to separate.
So, there is still a need to develop a highly selective method, preferably catalytic, affording conjugated cyclic derivatives with high yield.
The present invention allows to solve the above problem by using a base having a boiling point superior to the boiling point of the compound of formula (I) in order to prepare a conjugated dienes of formula (I); i.e. beta isomer. To the best of our knowledge, the invention's conditions have never been reported in the prior art.
The invention relates to a novel process allowing the preparation of compound of formula (I), while limiting even preventing the formation of others regioisomers, using methodologies never reported or suggested in the prior art.
So, a first object of the present invention is a process for the preparation of a compound of formula (I)
Another object of the present invention is a compound of formula
A further object of the present invention is a compound of formula
in a form of any one of its stereoisomers or a mixture thereof and wherein R1, R2, R3, R4 and R5, independently from each other, represent a hydrogen atom, a C1-6 alkyl group or a C2-6 alkenyl group; or R4 and R5 are taken together and form a C3-6 cycloalkyl group; X is a C(O)R6, COOR6, CN or C═NR6 group wherein R6 represents a hydrogen atom, a C1-6 alkyl group or a C2-6 alkenyl group; provided that ethyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate, methyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)ethan-1-one and 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one are excluded.
Surprisingly, it has now been discovered that the compound of formula (I) can be produced in an advantageous manner by reacting compound of formula (II) with a base having a boiling point superior to the boiling point of the compound of formula (I). This unprecedented step allows the generation of compound of formula (I) with a high selectivity toward the beta isomer, limiting even avoiding the formation of the alpha and/or gamma isomers.
Therefore, a first object of the present invention is a process for the preparation of a compound of formula (I)
For the sake of clarity, by the expression “any one of its stereoisomers or a mixture thereof”, or the similar, it is meant the normal meaning understood by a person skilled in the art, i.e. that the compounds cited in the invention can be a pure enantiomer or a mixture of enantiomers. In other words, the compounds cited in the invention may possess at least one stereocenter which can have two different stereochemistries (e.g. R or S), e.g. the R1 group may comprise at least one stereocenter. Said compounds may even be in the form of a pure enantiomer or in the form of a mixture of enantiomers. The compounds cited in the invention may even be in the form of a pure diastereoisomer or in the form of a mixture of diastereoisomers when said compounds possess more than one stereocenter or at least one double bond. Said compounds can be in a racemic form or scalemic form. Therefore, said compounds can be one stereoisomer or in the form of a composition of matter comprising, or consisting of, various stereoisomers.
According to any one of the above embodiments of the invention, said compounds can be in the form of its E or Z isomer or of a mixture thereof, e.g. the invention comprises compositions of matter consisting of one or more compounds of formula (I) and (II), having the same chemical structure but differing by the configuration of the double bond. In particular, compound (I) and compound (II) can be in the form of a mixture consisting of isomers E and Z.
The term “optionally” is understood that a group can or cannot be substituted. The term “one or more” is understood as comprising 1 to 7, preferably, 1 to 5, preferably, 1 to 3 functional groups and more preferably 1 or 2 functional groups.
The terms “alkyl” and “alkenyl” are understood as comprising branched and linear alkyl and alkenyl groups.
The term “alkenyl” is understood as comprising 1, 2 or 3 olefinic double bonds, preferably 1 or 2 olefinic double bonds.
The term “C3-6 cycloalkyl” is understood as a saturated ring comprising from 3 to 6 carbon atoms and including the carbon atom to which said R4 and R5 groups are bonded.
The term “aryl” is understood as comprising any group comprising at least one aromatic group such as phenyl, indenyl, indanyl, tetrahydronaphthalenyl or naphthalenyl group.
The term “CN group” is understood as a nitril group; i.e. —C≡N group.
According to any embodiment of the invention, n may be an integer between 0 and 10, particularly between 0 and 8, particularly between 0 and 6, particularly between 0 and 4. Particularly, n may be 0, 1 or 2. Even More particularly, n may be 1.
According to any embodiment of the invention, R2 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R2 may be a hydrogen atom or a C1-3 alkyl group. R2 may be a hydrogen atom, a methyl or an ethyl group. Even more particularly, R2 may be a hydrogen atom.
According to any embodiment of the invention, R3 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R3 may be a hydrogen atom or a C1-3 alkyl group. R3 may be a hydrogen atom, a methyl or an ethyl group. Even more particularly, R3 may be a hydrogen atom.
According to any embodiment of the invention, the compound of formula (I) is a compound of formula
in a form of any one of its stereoisomers or a mixture thereof and wherein n, R1, R4 and R5 have the same meaning as defined above.
According to any embodiment of the invention, the compound of formula (II) is a compound of formula
in a form of any one of its stereoisomers and wherein n, X, R1, R4, R5 and R7 have the same meaning as defined above.
According to any embodiment of the invention, R1 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R1 may be a hydrogen atom or a C1-3 alkyl group. R1 may be a hydrogen atom, a methyl or an ethyl group. Even more particularly, R1 may be a methyl or an ethyl group.
According to any embodiment of the invention, R4 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R4 may be a hydrogen atom or a C1-3 alkyl group. R4 may be a hydrogen atom, a methyl or an ethyl group. Even more particularly, R4 may be a methyl or an ethyl group.
According to any embodiment of the invention, R5 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R5 may be a hydrogen atom or a C1-3 alkyl group. R5 may be a hydrogen atom, a methyl or an ethyl group. Even more particularly, R5 may be a methyl or an ethyl group.
According to any embodiment of the invention, R4 and R5 may be taken together and form a C3-5 cycloalkyl group. Particularly, R4 and R5 may be taken together and form a C3 cycloalkyl group.
According to any embodiment of the invention, R6 may be a hydrogen atom, a C1-4 alkyl group or a C2-4 alkenyl group. Particularly, R6 may be a hydrogen atom, a C1-3 alkyl group or a C2-3 alkenyl group. R6 may be a hydrogen atom, a methyl, an ethyl or a prop-1-en-1-yl group. Even more particularly, R6 may be a methyl or an ethyl group.
According to any embodiment of the invention, X may be a C(O)R6 or COOR6 group wherein R6 has the same meaning as defined above.
According to any embodiment of the invention, R7 may be a hydrogen atom, a C2-4 alkenyl group, a C1-4 alkyl group optionally substituted by one, two or three halogen atoms, or a phenyl group optionally substituted by one or more of a hydroxy, C1-6 alkyl, C2-6 alkenyl, C1-6 alkoxy group and/or halogen atom. Particularly, R7 may be a hydrogen atom, a C2-4 alkenyl group, a C1-4 alkyl group optionally substituted by one, two or three halogen atoms, or a phenyl group optionally substituted by one or more of a hydroxy, C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy group and/or halogen atom. Particularly, R7 may be a hydrogen atom, a C2-3 alkenyl group, a C1-3 alkyl group optionally substituted by one, two or three halogen atoms, or a phenyl group, optionally substituted by one or more of a hydroxy, C1-3 alkyl, C2-3 alkenyl, C1-3 alkoxy group and/or halogen atom. Particularly, R7 may be a methyl, ethyl, propyl, isopropyl or phenyl group. Even more particularly, R7 may be a methyl group.
Non-limiting examples of suitable compounds of formula (I) may include 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, 2-methyl-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)-2-methylbut-2-en-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, 1-(5-methylspiro[2.5]octa-4,6-dien-4-yl)but-2-en-1-one, 1-(5-methylspiro[2.5]octa-4,6-dien-4-yl)ethan-1-one, 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)ethan-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)ethan-1-one, methyl or ethyl 6-ethyl-2,6-dimethylcyclohexa-1,3-diene-1-carboxylate, methyl or ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, 1-(2,5,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, methyl or ethyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate, methyl or ethyl 2,5,6-trimethylcyclohexa-1,3-diene-1-carboxylate, methyl or ethyl 5-methylspiro[2.5]octa-4,6-diene-4-carboxylate.
Non-limiting examples of suitable compounds of formula (II) may include 4-acetyl-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 4-(but-2-enoyl)-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 3,5,5-trimethyl-4-(2-methylbut-2-enoyl)cyclohex-2-en-1-yl acetate, 5-ethyl-3,5-dimethyl-4-(2-methylbut-2-enoyl)cyclohex-2-en-1-yl acetate, 4-(but-2-enoyl)-5-ethyl-3,5-dimethylcyclohex-2-en-1-yl acetate, 8-(but-2-enoyl)-7-methylspiro[2.5]oct-6-en-5-yl acetate, 4-acetyl-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 4-acetyl-5-ethyl-3,5-dimethylcyclohex-2-en-1-yl acetate, 8-acetyl-7-methylspiro[2.5]oct-6-en-5-yl acetate, methyl or ethyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate, methyl or ethyl 4-acetoxy-2,6,6-trimethylcyclohex-2-ene-1-carboxylate, methyl or ethyl 4-acetoxy-6-ethyl-2,6-dimethylcyclohex-2-ene-1-carboxylate, methyl or ethyl 4-acetoxy-2,5,6-trimethylcyclohex-2-ene-1-carboxylate, 4-(but-2-enoyl)-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 4-(but-2-enoyl)-3,5,6-trimethylcyclohex-2-en-1-yl acetate, methyl or ethyl 4-acetoxy-2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate, methyl or ethyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate.
According to any embodiments of the invention, the base has a boiling point of at least 5° C. greater than the boiling point of the compound of formula (I). Particularly, the base has a boiling point of at least 10° C., 15° C. or even 20° C. greater than the boiling point of the compound of formula (I).
According to any embodiments of the invention, the base is a metal carboxylate, a metal bicarbonate or a metal carbonate.
According to any embodiments of the invention, the metal carbonate is of formula
MpCO3 (III)
According to any embodiments of the invention, the metal bicarbonate is of formula
M(HOCO2)q (IV)
According to any embodiments of the invention, the metal carboxylate is of formula
(RCOO)rM (V)
It is understood that by “ . . . hydrocarbon group . . . ” it is meant that said group consists of hydrogen and carbon atoms and can be in the form of an aliphatic hydrocarbon, i.e. linear or branched saturated hydrocarbon (e.g. alkyl group), a linear or branched unsaturated hydrocarbon (e.g. alkenyl or alkynyl group), a saturated cyclic hydrocarbon (e.g. cycloalkyl) or an unsaturated cyclic hydrocarbon (e.g. cycloalkenyl or cycloalkynyl), or can be in the form of an aromatic hydrocarbon, i.e. aryl group, or can also be in the form of a mixture of said type of groups, e.g. a specific group may comprise a linear alkyl, a branched alkenyl (e.g. having one or more carbon-carbon double bonds), a (poly)cycloalkyl and an aryl moiety, unless a specific limitation to only one type is mentioned. Similarly, in all the embodiments of the invention, when a group is mentioned as being in the form of more than one type of topology (e.g. linear, cyclic or branched) and/or being saturated or unsaturated (e.g. alkyl, aromatic or alkenyl), it is also meant a group which may comprise moieties having any one of said topologies or being saturated or unsaturated, as explained above. Similarly, in all the embodiments of the invention, when a group is mentioned as being in the form of one type of saturation or unsaturation, (e.g. alkyl), it is meant that said group can be in any type of topology (e.g. linear, cyclic or branched) or having several moieties with various topologies.
According to any embodiments of the invention, M may be selected from the group of magnesium, calcium, potassium, sodium and lithium, preferably potassium.
According to any embodiments of the invention, the invention's process is performed in the presence of a metal carboxylate.
According to any embodiments of the invention, R may be a hydrogen atom or a C1-15 hydrocarbon group. Particularly, R may be a hydrogen atom, a phenyl group or a C1-15 alkyl group or C2-15 alkenyl group. Particularly, R may be a hydrogen atom, a phenyl group or a C1-10 alkyl group or C2-10 alkenyl group. Particularly, R may be a hydrogen atom, a phenyl group or a C1-8 alkyl group or C2-8 alkenyl group. Particularly, R may be a hydrogen atom, a phenyl group or a C1-6 alkyl group. Particularly, R may be a hydrogen atom, a phenyl group or a C1-3 alkyl group. Even more particularly, R may be a methyl group.
Non-limiting examples of suitable of metal carbonate may include potassium carbonate, magnesium carbonate, calcium carbonate, sodium carbonate or lithium carbonate.
Non-limiting examples of suitable of metal bicarbonate may include potassium bicarbonate, magnesium bicarbonate, calcium bicarbonate, sodium bicarbonate or lithium bicarbonate
Non-limiting examples of suitable of metal carboxylate may include potassium acetate, magnesium acetate, sodium acetate, calcium acetate, lithium acetate, potassium benzoate, magnesium benzoate, sodium benzoate, calcium benzoate, lithium benzoate potassium propionate, magnesium propionate, sodium propionate, calcium propionate, lithium propionate, potassium octoate, magnesium octoate, sodium octoate, calcium octoate, lithium octoate, potassium 2-ethylhexanoate, magnesium 2-ethylhexanoate, sodium 2-ethylhexanoate, calcium 2-ethylhexanoate or lithium 2-ethylhexanoate.
The metal bicarbonate or carbonate can be added into the reaction medium of the invention's process to form compound of formula (I) in a large range of concentrations. As non-limiting examples, one can cite, as metal bicarbonate or carbonate concentration values those ranging from 1 mol % to 10 equivalents, relative to the total amount of compound of formula (II). Particularly, the metal bicarbonate or carbonate concentration may be comprised between 1 mol % to 5 equivalents. Particularly, the metal bicarbonate or carbonate concentration may be comprised between 1.2 mol % to 2 equivalents. It goes without saying that the process works also with more metal bicarbonate or carbonate. However the optimum concentration of metal bicarbonate or carbonate will depend, as the person skilled in the art knows, on the nature of the latter, on the nature of the compound of formula (II), on the temperature and on the desired time of reaction.
According to any embodiments of the invention, the invention's process is carried out in the presence of a catalytic amount of the metal carboxylate.
The metal carboxylate can be added into the reaction medium of the invention's process to form compound of formula (I) in a large range of concentrations. As non-limiting examples, one can cite, as metal carboxylate concentration values those ranging from 0.1 mol % to 100 mol %, relative to the total amount of compound of formula (II). Particularly, the metal carboxylate concentration may be comprised between 1 mol % to 50 mol %. Particularly, the metal carboxylate concentration may be comprised between 2 mol % to 20 mol %. Even more particularly, the metal carboxylate concentration may be comprised between 5 mol % to 15 mol %. It goes without saying that the process works also with more metal carboxylate. However the optimum concentration of metal carboxylate will depend, as the person skilled in the art knows, on the nature of the latter, on the nature of the compound of formula (II), on the temperature and on the desired time of reaction.
The invention's process to form compound of formula (I) is carried out under batch, semi continuous or continuous conditions.
According to any embodiments of the invention, the more volatile compounds generated during the invention's process such as the compound of formula (I) and, optionally the carboxylic acid of formula R7COOH, are removed continuously during the process, for example, by distillation at atmospheric pressure or under reduced pressure.
The invention's process may be performed under inert atmosphere such as nitrogen or argon. The invention's process may be performed under atmospheric pressure or under a slight vacuum. Particularly, the invention's process can be carried out at a pressure comprised between 100 Pa and 10000 Pa (1 to 100 mbars), particularly, between 3000 Pa and 5000 Pa (30 to 50 mbars). A person skilled in the art is well able to adjust the pressure as a function of the compound of formula (II) and (I) and the solvent.
The invention's process to form compound of formula (I) can be carried out in the presence or absence of a solvent. When a solvent is required or used for practical reasons, then any solvent current in such reaction type can be used for the purposes of the invention, particularly at least one aprotic dipolar solvent. Non-limiting examples include 2-pyrrolidone, N-Methylpyrrolidone, N-octylpyrrolidone, dimethylformamide, dimethylacetamide, dimethylsulfoxide, sulfolane, hexamethyl phosphoramide or a mixture thereof. The choice of the solvent is function of the nature of the compound of formula (II) and/or the base and the person skilled in the art is well able to select the solvent most suitable in each case to optimize the reaction.
According to any one of the invention's embodiments, the invention's process to form compound of formula (I) is carried out at a temperature comprised between 80° C. and 250° C. In particular, the temperature is in the range between 100° C. and 200° C. A person skilled in the art is also able to select the preferred temperature as a function of the melting and boiling point of the starting and final products as well as the desired time of reaction or conversion.
The compound of formula (I), and (II) are, generally, novel compounds and present a number of advantages as explained above and shown in the Examples.
Therefore, another object of the present invention is a compound of formula
According to any embodiment of the invention, the compound of formula (II) may be selected in the group consisting of 4-acetyl-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 3,5,5-trimethyl-4-(2-methylbut-2-enoyl)cyclohex-2-en-1-yl acetate, 5-ethyl-3,5-dimethyl-4-(2-methylbut-2-enoyl)cyclohex-2-en-1-yl acetate, 4-(but-2-enoyl)-5-ethyl-3,5-dimethylcyclohex-2-en-1-yl acetate, 8-(but-2-enoyl)-7-methylspiro[2.5]oct-6-en-5-yl acetate, 4-acetyl-3,5,5-trimethylcyclohex-2-en-1-yl acetate, 4-acetyl-5-ethyl-3,5-dimethylcyclohex-2-en-1-yl acetate, 8-acetyl-7-methylspiro[2.5]oct-6-en-5-yl acetate, methyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate, ethyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate, methyl 4-acetoxy-2,6,6-trimethylcyclohex-2-ene-1-carboxylate, methyl 4-acetoxy-6-ethyl-2,6-dimethylcyclohex-2-ene-1-carboxylate,ethyl 4-acetoxy-6-ethyl-2,6-dimethylcyclohex-2-ene-1-carboxylate, 4-(but-2-enoyl)-3,5,6-trimethylcyclohex-2-en-1-yl acetate, methyl 4-acetoxy-2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate, ethyl 4-acetoxy-2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate, methyl 4-acetoxy-2,5,6-trimethylcyclohex-2-ene-1-carboxylate, ethyl 4-acetoxy-2,5,6-trimethylcyclohex-2-ene-1-carboxylate, methyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate and ethyl 7-acetoxy-5-methylspiro[2.5]oct-5-ene-4-carboxylate.
Another object of the present invention is a compound of formula
in a form of any one of its stereoisomers or a mixture thereof and wherein R1, R2, R3, R4 and R5, independently from each other, represent a hydrogen atom, a C1-6 alkyl group or a C2-6 alkenyl group; or R4 and R5 are taken together and form a C3-6 cycloalkyl group; X is a C(O)R6, COOR6, CN or C═NR6 group wherein R6 represents a hydrogen atom, a C1-6 alkyl group or a C2-6 alkenyl group; provided that ethyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate, methyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)ethan-1-one and 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one are excluded.
According to any embodiment of the invention, the compound of formula (I) may be selected in the group consisting of 2-methyl-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)-2-methylbut-2-en-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, 1-(5-methylspiro[2.5]octa-4,6-dien-4-yl)but-2-en-1-one, 1-(5-methylspiro[2.5]octa-4,6-dien-4-yl)ethan-1-one, 1-(6-ethyl-2,6-dimethylcyclohexa-1,3-dien-1-yl)ethan-1-one, methyl 6-ethyl-2,6-dimethylcyclohexa-1,3-diene-1-carboxylate, ethyl 6-ethyl-2,6-dimethylcyclohexa-1,3-diene-1-carboxylate, 1-(2,5,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, methyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate, ethyl 5-methylspiro[2.5]octa-4,6-diene-4-carboxylate, methyl 5-methylspiro[2.5]octa-4,6-diene-4-carboxylate, methyl 2,5,6-trimethylcyclohexa-1,3-diene-1-carboxylate, and ethyl 2,5,6-trimethylcyclohexa-1,3-diene-1-carboxylate.
Said compound of formula (I) can be used as perfuming ingredient, for instance to impart odor notes of the amber type. So another object of the invention is the use as perfuming ingredient of the invention's compound of formula (I) as defined above. In other words, it concerns a method or a process to confer, enhance, improve or modify the odor properties of a perfuming composition or of a perfumed article or of a surface, which method comprises adding to said composition or article an effective amount of the invention's composition of matter, e.g. to impart its typical note. Understood that the final hedonic effect may depend on the precise dosage and on the organoleptic properties of the invention's composition of matter, but anyway the addition of the invention's compound of formula (I) will impart to the final product its typical touch in the form of a note, touch or aspect depending on the dosage.
By “use of the the invention's compound of formula (I)” it has to be understood here also the use of any composition containing the invention's compound of formula (I) and which can be advantageously employed in the perfumery industry.
Said compositions, which in fact can be advantageously employed as perfuming ingredients, are also an object of the present invention.
Therefore, another object of the present invention is a perfuming composition comprising:
By “perfumery carrier” it is meant here a material which is practically neutral from a perfumery point of view, i.e. that does not significantly alter the organoleptic properties of perfuming ingredients. Said carrier may be a liquid or a solid.
As liquid carrier one may cite, as non-limiting examples, an emulsifying system, i.e. a solvent and a surfactant system, or a solvent commonly used in perfumery. A detailed description of the nature and type of solvents commonly used in perfumery cannot be exhaustive. However, one can cite as non-limiting examples, solvents such as butylene or propylene glycol, glycerol, dipropyleneglycol and its monoether, 1,2,3-propanetriyl triacetate, dimethyl glutarate, dimethyl adipate 1,3-diacetyloxypropan-2-yl acetate, diethyl phthalate, isopropyl myristate, Abalyn® (rosin resins, available from Eastman), benzyl benzoate, benzyl alcohol, 2-(2-ethoxyethoxy)-1-ethanol, tri-ethyl citrate or mixtures thereof, which are the most commonly used or also naturally derived solvents like glycerol or various vegetable oils such as palm oil, sunflower oil or linseed oil. For the compositions which comprise both a perfumery carrier and a perfumery base, other suitable perfumery carriers than those previously specified, can be also ethanol, water/ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trademark Isopar® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trademark Dowanol® (origin: Dow Chemical Company), or hydrogenated castors oils such as those known under the trademark Cremophor® RH 40 (origin: BASF).
Solid carrier is meant to designate a material to which the perfuming composition or some element of the perfuming composition can be chemically or physically bound. In general such solid carriers are employed either to stabilize the composition, or to control the rate of evaporation of the compositions or of some ingredients. Solid carriers are of current use in the art and a person skilled in the art knows how to reach the desired effect. However by way of non-limiting examples of solid carriers, one may cite absorbing gums or polymers or inorganic materials, such as porous polymers, cyclodextrins, dextrins, maltodextrines wood based materials, organic or inorganic gels, clays, gypsum talc or zeolites.
As other non-limiting examples of solid carriers, one may cite encapsulating materials. Examples of such materials may comprise wall-forming and plasticizing materials, such as glucose syrups, natural or modified starches, hydrocolloids, cellulose derivatives, polyvinyl acetates, polyvinylalcohols, proteins or pectins, plant gums such as acacia gum (Gum Arabic), urea, sodium chloride, sodium sulfate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, carbohydrates, saccharides such as sucrose, mono-, di-, tri- and polysaccharides and derivatives such as chitosan, starch, cellulose, carboxymethyl methylcellulose, methylcellulose, hydroxyethyl cellulose, ethyl cellulose, propyl cellulose, polyols/sugar alcohols such as sorbitol, maltitol, xylitol, erythritol, and isomalt, polyethylene glycol (PEG), polyvinyl pyrrolidin (PVP), polyvinyl alcohol, acrylamides, acrylates, polyacrylic acid and related structures, maleic anhydride copolymers, amine-functional polymers, vinyl ethers, styrenes, polystyrenesulfonates, vinyl acids, ethylene glycol-propylene glycol block copolymers, vegetable gums, gum acacia, pectins, xanthanes, alginates, carragenans, citric acid or any water soluble solid acid, fatty alcohols or fatty acids and mixtures thereof, or yet the materials cited in reference texts such as H. Scherz, Hydrokolloide: Stabilisatoren, Dickungs- und Geliermittel in Lebensmitteln, Band 2 der Schriftenreihe Lebensmittelchemie, Lebensmittelqualität, Behr's Verlag GmbH & Co., Hamburg, 1996. The encapsulation is a well-known process to a person skilled in the art, and may be performed, for instance, by using techniques such as spray-drying, agglomeration or yet extrusion; or consists of a coating encapsulation, including coacervation and complex coacervation techniques.
As non-limiting examples of solid carriers, one may cite in particular the core-shell capsules with resins of aminoplast, polyamide, polyester, polyurea or polyurethane type or a mixture thereof (all of said resins are well known to a person skilled in the art) using techniques like phase separation process induced by polymerization, interfacial polymerization, coacervation or altogether (all of said techniques have been described in the prior art), optionally in the presence of a polymeric stabilizer or of a cationic copolymer.
Resins may be produced by the polycondensation of an aldehyde (e.g. formaldehyde, 2,2-dimethoxyethanal, glyoxal, glyoxylic acid or glycolaldehyde and mixtures thereof) with an amine such as urea, benzoguanamine, glycouryl, melamine, methylol melamine, methylated methylol melamine, guanazole and the like, as well as mixtures thereof. Alternatively, one may use preformed resins alkylolated polyamines such as those commercially available under the trademark Urac® (origin: Cytec Technology Corp.), Cymel® (origin: Cytec Technology Corp.), Urecoll® or Luracoll® (origin: BASF).
Other resins are the ones produced by the polycondensation of a polyol, like glycerol, and a polyisocyanate, like a trimer of hexamethylene diisocyanate, a trimer of isophorone diisocyanate or xylylene diisocyanate or a Biuret of hexamethylene diisocyanate or a trimer of xylylene diisocyanate with trimethylolpropane (known with the tradename of Takenate®, origin: Mitsui Chemicals), among which a trimer of xylylene diisocyanate with trimethylolpropane and a Biuret of hexamethylene diisocyanate are preferred.
Some of the seminal literature related to the encapsulation of perfumes by polycondensation of amino resins, namely melamine based resins with aldehydes includes articles such as those published by K. Dietrich et al. Acta Polymerica, 1989, Vol. 40, pages 243, 325 and 683, as well as 1990, Vol. 41, page 91. Such articles already describe the various parameters affecting the preparation of such core-shell microcapsules following prior art methods that are also further detailed and exemplified in the patent literature. US 4,396,670, to the Wiggins Teape Group Limited is a pertinent early example of the latter. Since then, many other authors have enriched the literature in this field and it would be impossible to cover all published developments here, but the general knowledge in encapsulation technology is very significant. More recent publications of pertinence, which disclose suitable uses of such microcapsules, are represented for example by the article of K. Bruyninckx and M. Dusselier, ACS Sustainable Chemistry & Engineering, 2019, vol. 7, pages 8041-8054.
By “perfumery base” what is meant here is a composition comprising at least one perfuming co-ingredient.
Said perfuming co-ingredient is not compound of formula (I). Moreover, by “perfuming co-ingredient” it is meant here a compound, which is used in a perfuming preparation or a composition to impart a hedonic effect; i.e. used for the primary purpose of conferring or modulating an odor. In other words such a co-ingredient, to be considered as being a perfuming one, must be recognized by a person skilled in the art as being able to impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor. The perfuming co-ingredient may impart an additional benefit beyond that of modifying or imparting an odor, such as long-lasting, blooming, malodour counteraction, antimicrobial effect, antiviral effect, microbial stability, or pest control.
The nature and type of the perfuming co-ingredients present in the base do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of his general knowledge and according to the intended use or application and the desired organoleptic effect. In general terms, these perfuming co-ingredients belong to chemical classes as varied as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, thiols, terpene hydrocarbons, nitrogenous or sulfurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin.
In particular one may cite perfuming co-ingredients which are commonly used in perfume formulations, such as:
A perfumery base according to the invention may not be limited to the above-mentioned perfuming co-ingredients, and many other of these co-ingredients are in any case listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA, or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of perfumery. It is also understood that said co-ingredients may also be compounds known to release in a controlled manner various types of perfuming compounds also known as properfume or profragrance. Non-limiting examples of suitable properfume may include 4-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 4-(dodecylthio)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butanone, trans-3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 3-(dodecylsulfonyl)-1-(2,6,6-trimethylcyclohex-3-en-1-yl)butan-1-one, a linear polysiloxane co-polymer of (3-mercaptopropyl)(methyl)dimethoxysilane, 1-[6-ethyl-2,6-dimethyl-3-cyclohexen-1-yl]-2-buten-1-one, 2-(dodecylthio)octan-4-one, 2-(dodecylsulfonyl)octan-4-one, 4-oxooctan-2-yl dodecanoate, 2-phenylethyl oxo(phenyl)acetate, 3,7-dimethylocta-2,6-dien-1-yl oxo(phenyl)acetate, (Z)-hex-3-en-1-yl oxo(phenyl)acetate, 3,7-dimethyl-2,6-octadien-1-yl hexadecanoate, bis(3,7-dimethylocta-2,6-dien-1-yl) succinate, (2E,6Z)-2,6-nonadienyl hexadecanoate, (2E,6Z)-2,6-nonadien-1-yl tetradecanoate, (2E,6Z)-2,6-nonadien-1-yl dodecanoate, (2-((2-methylundec-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(3-methyl-4-phenethoxybut-3-en-1-yl)benzene, (3-methyl-4-phenethoxybut-3-en-1-yl)benzene, 1-(((Z)-hex-3-en-1-yl)oxy)-2-methylundec-1-ene, (2-((2-methylundec-1-en-1-yl)oxy)ethoxy)benzene, 2-methyl-1-(octan-3-yloxy)undec-1-ene, 1-methoxy-4-(1-phenethoxyprop-1-en-2-yl)benzene, 1-methyl-4-(1-phenethoxyprop-1-en-2-yl)benzene, 2-(1-phenethoxyprop-1-en-2-yl)naphthalene, (2-phenethoxyvinyl)benzene, 2-(1-((3,7-dimethyloct-6-en-1-yl)oxy)prop-1-en-2-yl)naphthalene, (2-((2-pentylcyclopentylidene)methoxy)ethyl)benzene, 4-allyl-2-methoxy-1-((2-methoxy-2-phenylvinyl)oxy)benzene, (2-((2-heptylcyclopentylidene)methoxy)ethyl)benzene, 1-methoxy-4-(1-phenethoxyprop-1-en-2-yl)benzene, (2-((2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(2-methyl-3-phenethoxyallyl)benzene, (2-((2-isopropyl-5-methylcyclohexylidene)methoxy)ethyl)benzene, 1-isopropyl-4-methyl-2-((2-pentylcyclopentylidene)methoxy)benzene, 2-methoxy-1-((2-pentylcyclopentylidene)methoxy)-4-propylbenzene, 2-ethoxy-1-((2-methoxy-2-phenylvinyl)oxy)-4-methylbenzene, 3-methoxy-4-((2-methoxy-2-phenylvinyl)oxy)benzaldehyde, 1-isopropyl-2-((2-methoxy-2-phenylvinyl)oxy)-4-methylbenzene, 4-((2-(hexyloxy)-2-phenylvinyl)oxy)-3-methoxybenzaldehyde or a mixture thereof.
By “perfumery adjuvant”, it is meant here an ingredient capable of imparting additional added benefit such as a color, a particular light resistance, chemical stability, etc. A detailed description of the nature and type of adjuvant commonly used in perfuming composition cannot be exhaustive, but it has to be mentioned that said ingredients are well known to a person skilled in the art. One may cite as specific non-limiting examples the following: viscosity agents (e.g. surfactants, thickeners, gelling and/or rheology modifiers), stabilizing agents (e.g. preservatives, antioxidant, heat/light and or buffers or chelating agents, such as BHT), coloring agents (e.g. dyes and/or pigments), preservatives (e.g. antibacterial or antimicrobial or antifungal or anti irritant agents), abrasives, skin cooling agents, fixatives, insect repellants, ointments, vitamins and mixtures thereof. By “fixative” also called “modulator”, it is understood here an agent having the capacity to affect the manner in which the odour, and in particular the evaporation rate and intensity, of the compositions incorporating said modulator can be perceived by an observer or user thereof, over time, as compared to the same perception in the absence of the modulator. In particular, the modulator allows prolonging the time during which their fragrance is perceived. Non-limiting examples of suitable modulators may include methyl glucoside polyol; ethyl glucoside polyol; propyl glucoside polyol; isocetyl alcohol; PPG-3 myristyl ether; neopentyl glycol diethylhexanoate; sucrose laurate; sucrose dilaurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose distearate, sucrose tristearate, hyaluronic acid disaccharide sodium salt, sodium hyaluronate, propylene glycol propyl ether; dicetyl ether; polyglycerin-4 ethers; isoceteth-5; isoceteth-7, isoceteth-10; isoceteth-12; isoceteth-15; isoceteth-20; isoceteth-25; isoceteth-30; disodium lauroamphodipropionate; hexaethylene glycol monododecyl ether; and their mixtures; neopentyl glycol diisononanoate; cetearyl ethylhexanoate; panthenol ethyl ether, DL-panthenol, N-hexadecyl n-nonanoate, noctadecyl n-nonanoate, a profragrance, cyclodextrin, an encapsulation, and a combination thereof. At most 20% by weight, based on the total weight of the perfuming composition, of the modulator may be incorporated into the perfumed consumer product.
It is understood that a person skilled in the art is perfectly able to design optimal formulations for the desired effect by admixing the above mentioned components of a perfuming composition, simply by applying the standard knowledge of the art as well as by trial and error methodologies.
An invention's composition consisting of the invention's compound of formula (I) and at least one perfumery carrier consists of a particular embodiment of the invention as well as a perfuming composition comprising the invention's composition of matter, at least one perfumery carrier, at least one perfumery base, and optionally at least one perfumery adjuvant.
For the sake of clarity, it is also understood that any mixture resulting directly from a chemical synthesis, e.g. a reaction medium without an adequate purification, in which the invention's compound of formula (I) would be involved as a starting, intermediate or end-product could not be considered as a perfuming composition according to the invention as far as said mixture does not provide the inventive compound of formula (I) in a suitable form for perfumery. Thus, unpurified reaction mixtures are generally excluded from the present invention unless otherwise specified.
The invention's compound of formula (I) can also be advantageously used in all the fields of modern perfumery, i.e. fine or functional perfumery, to positively impart or modify the odor of a consumer product into which said invention's compound of formula (I) is added. Consequently, another object of the present invention consists of a perfumed consumer product comprising, as a perfuming ingredient, the invention's composition of matter, as defined above.
The invention's compound of formula (I) can be added as such or as part of an invention's perfuming composition.
For the sake of clarity, “perfumed consumer product” is meant to designate a consumer product which delivers at least a pleasant perfuming effect to the surface or space to which it is applied (e.g. skin, hair, textile, or home surface). In other words, a perfumed consumer product according to the invention is a perfumed consumer product which comprises a functional formulation, as well as optionally additional benefit agents, corresponding to the desired consumer product, and an olfactive effective amount of at least one invention's compound. For the sake of clarity, said perfumed consumer product is a non-edible product.
The nature and type of the constituents of the perfumed consumer product do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of his general knowledge and according to the nature and the desired effect of said product.
Non-limiting examples of suitable perfumed consumer products include a perfume, such as a fine perfume, a splash or eau de parfum, a cologne or a shave or after-shave lotion; a fabric care product, such as a liquid or solid detergent optionally in the form of a pod or tablet, a fabric softener, a liquid or solid scent booster, a dryer sheet, a fabric refresher, an ironing water, a paper, a bleach, a carpet cleaner, a curtain-care product; a body-care product, such as a hair care product (e.g. a shampoo, a leave-on or rinse-off hair conditioner, a coloring preparation or a hair spray, a color-care product, a hair shaping product, a dental care product), a disinfectant, an intimate care product; a cosmetic preparation (e.g. a skin cream or lotion, a vanishing cream or a deodorant or antiperspirant (e.g. a spray or roll on), a hair remover, a tanning or sun or after sun product, a nail product, a skin cleansing, a makeup); or a skin-care product (e.g. a soap, a shower or bath mousse, oil or gel, or a hygiene product or a foot/hand care products); an air care product, such as an air freshener or a “ready to use” powdered air freshener which can be used in the home space (rooms, refrigerators, cupboards, shoes or car) and/or in a public space (halls, hotels, malls, etc.); or a home care product, such as a mold remover, a furnisher care product, a wipe, a dish detergent or a hard-surface (e.g. a floor, bath, sanitary or a window-cleaning) detergent; a leather care product; a car care product, such as a polish, a wax or a plastic cleaner.
Some of the above-mentioned perfumed consumer products may represent an aggressive medium for the invention's composition of matter, so that it may be necessary to protect the latter from premature decomposition, for example by encapsulation or by chemically binding it to another chemical which is suitable to release the invention's compound of formula (I) upon a suitable external stimulus, such as an enzyme, light, heat or a change of pH.
Typical manners to execute the invention's process are reported herein below in the examples.
The invention will now be described in further detail by way of the following examples, wherein the abbreviations have the usual meaning in the art, the temperatures are indicated in degrees centigrade (° C.). The solvents were dried by conventional procedures and distilled under an argon atmosphere. NMR spectra were recorded at 20° C. on Bruker AV 300, AV 400, or AV 500 MHz spectrometers. Chemical shifts are reported in ppm relative to solvent signals (chloroform, δH=7.26 ppm, δC=77.0 ppm). The signal assignment was ensured by recording 1H,1H-COSY, -NOESY, 13C,1H-HSQC and -HMBC experiments. Gas chromatography was performed on an Agilent 7890 A Series equipped with a HP5 column (30 m×0.25 mm ID, 0.25 μm film) and tetradecane was used as internal standard.
Into a 1 L glass reactor equipped with a mechanical stirrer, a packed column, a reflux condenser, 60 g (0.61 mol) of potassium acetate, 250 g of 2-pyrrolidone and 250 g (1.11 mol) of 4-acetyl-3,5,5-trimethylcyclohex-2-en-1-yl acetate were added. The reaction mixture was stirred and then heated to 135° C. while gradually decreasing the internal pressure to 40 mbar. The formed product with acetic acid all together were continuously distilled into a flask over 4 h. Then the reaction mixture was heated to 155° C. while the pressure was decreased to 25 mbar. The distillate was taken up separately into another vessel to be neutralized by aqueous soda followed by washing with water. The subsequent fractionation of the resulting crude oil (188 g) at 65-80° C./5 mbar afforded 169 g of 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)ethan-1-one (92% yield). The analysis of the fraction by GC chromatography showed 97% of 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)ethan-1-one, 1.8% of 1-(6,6-dimethyl-2-methylenecyclohex-3-en-1-yl)ethan-1-one and 0.2% of 1-(2,6,6-trimethylcyclohexa-2,4-dien-1-yl)ethan-1-one.
H1-NMR (CDCl3, 500 MHz) δ 1.09 (s, 6H); 1.73 (s, 3H); 2.1 (dd, J1=4.1 Hz, J2=1.5 Hz, 2H); 2.3 (s, 3H); 5.81 (m, 2H).
13C-NMR (CDCl3, 125 MHz) δ 19.0 (q); 26.0 (2q); 33.1 (q); 33.7 (s); 39.8 (t); 126.2 (s); 127.4 (d); 128.1 (d); 142.3 (s); 208.3 (s).
Into a 1 L glass reactor equipped with a mechanical stirrer, a packed column, a reflux condenser, 50 g (0.50 mol) of potassium acetate, 200 g of 2-pyrrolidone and 300 g (1.18 mol) of ethyl 4-acetoxy-2,6,6-trimethylcyclohex-2-ene-1-carboxylate were added. The reaction mixture was stirred then heated to 155° C. while gradually decreasing the internal pressure to 50 mbar. The formed product with acetic acid all together were continuously distilled into a flask over 4 h. Then the reaction mass was heated to 165° C. while the pressure was decreased to 25 mbar. The distillate was taken up separately into another vessel to be neutralized by aqueous soda followed by washing with water. The subsequent fractionation of the resulting crude oil (228 g) at 65-80° C./3 mbar afforded 199 g of ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate (88% yield). The analysis of the fraction by GC chromatography showed 97.2% of ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate, 1.0% of ethyl 6,6-dimethyl-2-methylenecyclohex-3-ene-1-carboxylate and 1.0% of ethyl 2,6,6-trimethylcyclohexa-2,4-diene-1-carboxylate.
H1-NMR (CDCl3, 500 MHz) δ 1.12 (s, 6H); 1.33 (t, J=7.0 Hz, 3H); 1.81 (s, 3H); 2.1 (dd, J1=4.4 Hz, J2=1.7 Hz, 2H); 4.25 (q, J=7.0 Hz, 2H); 5.81 (m, 1H); 5.87 (m, 1H).
13C-NMR (CDCl3, 125 MHz) δ 14.4 (q); 19.5 (q); 25.8 (2q); 33.3 (s); 39.4 (t); 60.07 (t); 128.0 (d); 128.3 (d); 131.8 (s); 133.5 (s); 169.8 (s).
Into a 1 L glass reactor equipped with a mechanical stirrer, a packed column, a reflux condenser, 50 g (0.50 mol) of potassium acetate, 200 g of 2-pyrrolidone and 300 g (1.18 mol) of methyl 4-acetoxy-2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate were added. The reaction mixture was stirred and then heated to 155° C. while gradually decreasing the internal pressure to 50 mbar. The formed product with acetic acid all together were continuously distilled into a flask over 4 h. Then the reaction mass was heated to 165° C. while the pressure was decreased to 25 mbar. The distillate was taken up separately into another vessel to be neutralized by aqueous soda followed by washing with water. The subsequent fractionation of the resulting crude oil (231 g) at 65-80° C./3 mbar afforded 202 g of the methyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate (89.5% yield). The analysis of the fraction by GC chromatography shows 98.5% of methyl 2-ethyl-6,6-dimethylcyclohexa-1,3-diene-1-carboxylate, 0.3% of methyl 2-ethylidene-6,6-dimethylcyclohex-3-ene-1-carboxylate and 0.9% of methyl 2-ethyl-6,6-dimethylcyclohexa-2,4-diene-1-carboxylate.
H1-NMR (CDCl3, 500 MHz) δ 1.01 (t, 3H); 1.10 (s, 6H); 2.08 (q, 2H); 2.11 (d, 2H); 3.75 (s, 3H); 5.87 (d, 1H); 5.89 (m, 1H).
13C-NMR (CDCl3, 125 MHz) δ 13.5; 25.9; 25.9; 27; 33.2; 39.4; 51; 126.4; 128.8; 132.7; 137.5; 170.3.
Into a 1 L glass reactor equipped with a mechanical stirrer, a packed column, a reflux condenser, 50 g (0.50 mol) of potassium acetate, 200 g of 2-pyrrolidone and 300 g (1.18 mol) of ethyl 4-acetoxy-2,5,6-trimethylcyclohex-2-ene-1-carboxylate were added. The reaction mixture was stirred and then heated to 155° C. while gradually decreasing the internal pressure to 50 mbar. The formed product with acetic acid all together were continuously distilled into a flask over 4 h. Then the reaction mass was heated to 165° C. while the pressure was decreased to 25 mbar. The distillate was taken up separately into another vessel to be neutralized by aqueous soda followed by washing with water. The subsequent fractionation of the resulting crude oil (223 g) at 65-80° C./3 mbar afforded 194 g of 2,5,6-trimethylcyclohexa-1,3-diene-1-carboxylate (85% yield). The analysis of the fraction by GC chromatography shows 98% of 2,5,6-trimethylcyclohexa-1,3-diene-1-carboxylate (mix cis+trans 44:56), 0.5% of ethyl 5,6-dimethyl-2-methylenecyclohex-3-ene-1-carboxylate and 1.0% of ethyl 2,5,6-trimethylcyclohexa-2,4-diene-1-carboxylate.
H1-NMR (CDCl3, 500 MHz) δ 0.92 (d, 3H); 1.01 (d, 3H); 1.31 (t, 3H); 2.11 (m, 1H); 2.14 (s, 3H); 2.62 (m, 1H); 4.22 (q, 2H); 5.78 (d, 1H); 5.94 (m, 1H).
13C-NMR (CDCl3, 125 MHz) δ 14.4; 18.4; 18.8; 20.8; 35; 35.4; 59.9; 125.3; 127.9; 136.1; 139.9; 168.8.
H1-NMR (CDCl3, 500 MHz) δ 0.84 (d, 3H); 1.09 (d, 3H); 1.31 (t, 3H); 2.13 (s, 3H); 2.63 (m, 1H); 2.64 (m, 1H); 4.22 (q, 2H); 5.65 (d, 1H); 5.84 (m, 1H).
13C-NMR (CDCl3, 125 MHz) δ 10; 14.4; 15.9; 20.5; 33.1; 33.3; 59.9; 128.5; 130; 137; 141.2; 168.8.
| Number | Date | Country | Kind |
|---|---|---|---|
| 21210351.9 | Nov 2021 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2022/083079 | 11/24/2022 | WO |
